Dec 2024
Hi, folks;
I'm a 68yo male, eight weeks post-autologous bone marrow transplant (ABMT) after a slumbering multiple myeloma (SMM) diagnosis in 2013, active multiple myeloma (MM) diagnosis in April 2024, radiation treatment of plasmacytoma and bone lesions in May/June; Zometa infusions through Aug to help with bone lesions. Velcade/Daratumamab/Revlamid/Dexamethasone in June/July/Aug; stem cell collection in Sept and transplant Oct 14. Five days later was hospitalized for gut infections, diverticulitis and typhlitis, for 8 days. Lots of diarrhea, some nausea but no vomiting, fatigue, peripheral neuropathy (showing up as occasional sharp pains, which wake me up a night, but mostly numbness of feet, inhibiting balance and movement) and loss of 25 pounds (about 13% of body mass), much of which seems to be muscle mass. Will likely restart Zometa for bones, daratumamab and revlamid for maintenance next month. Question: Have been improving slowly in movement/ leg strength/balance; thoughts on how much improvement I can expect?

Your Feed
Filter by
See content from
Playlist: Chronic Lymphocytic Leukemia
A Unique BTK Inhibitor, Pirtobrutinib for Patients with Pretreated CLL | Jeff Sharman, MD | #ASH24
Video details & playlist
Playlist: ASH 2024
A Unique BTK Inhibitor, Pirtobrutinib for Patients with Pretreated CLL | Jeff Sharman, MD | #ASH24
Video details & playlist
Playlist: Chronic Lymphocytic Leukemia
Duvelisib + Venetoclax: A Time-Limited, All Oral Option for CLL | Jennifer Crombie, MD | #ASH24
Video details & playlist
Playlist: ASH 2024
Duvelisib + Venetoclax: A Time-Limited, All Oral Option for CLL | Jennifer Crombie, MD | #ASH24
Video details & playlist
Playlist: Diffuse Large B-Cell Lymphoma
Promising Results for Odronextamab in Post CAR T Patients with DLBCL | Jennifer Crombie, MD | #ASH24
Video details & playlist
Playlist: ASH 2024
Promising Results for Odronextamab in Post CAR T Patients with DLBCL | Jennifer Crombie, MD | #ASH24
Video details & playlist
Playlist: ASH 2024
Analyzing the Impact of Smoking on Myelodysplastic Syndromes | Sangeeth Venugopal, MD | #ASH24
Video details & playlist
Playlist: Myelodysplastic Syndromes
Analyzing the Impact of Smoking on Myelodysplastic Syndromes | Sangeeth Venugopal, MD | #ASH24
Video details & playlist
Playlist: Acute Myeloid Leukemia
Adding Venetoclax to 7+3 Chemotherapy in Newly Diagnosed AML | Ioannis Mantzaris, MD | #ASH24
Video details & playlist
Playlist: ASH 2024
Adding Venetoclax to 7+3 Chemotherapy in Newly Diagnosed AML | Ioannis Mantzaris, MD | #ASH24
Video details & playlist
Playlist: Multiple Myeloma
Understanding the ASH Research Collaborative- COSMIC Study | Saad Usmani, MD | #ASH24
Video details & playlist
Playlist: ASH 2024
Understanding the ASH Research Collaborative- COSMIC Study | Saad Usmani, MD | #ASH24
Video details & playlist
Playlist: Multiple Myeloma
Belantamab + Standard of Care for Newly Diagnosed Myeloma (DreaMM-9) | Saad Usmani, MD | #ASH24
Video details & playlist
Playlist: ASH 2024
Belantamab + Standard of Care for Newly Diagnosed Myeloma (DreaMM-9) | Saad Usmani, MD | #ASH24
Video details & playlist
Playlist: ASH 2024
Social Determinants of Health Impact Myeloma FISH Testing | Amy Pierre, MSN, RN, ANP-BC | #ASH24
Video details & playlist
Playlist: Multiple Myeloma
Social Determinants of Health Impact Myeloma FISH Testing | Amy Pierre, MSN, RN, ANP-BC | #ASH24
Video details & playlist
Playlist: ASH 2024
Dara-CyBorD vs CyBorD in Newly Diagnosed AL Amyloidosis| Hans Lee, MD | #ASH2024
Video details & playlist
Playlist: Multiple Myeloma
Dara-CyBorD vs CyBorD in Newly Diagnosed AL Amyloidosis| Hans Lee, MD | #ASH2024
Video details & playlist
Playlist: Multiple Myeloma
Cevostamab, a FcRH5 bispecific antibody, for RRMM | Joshua Richter, MD | #ASH2024
Video details & playlist
Playlist: ASH 2024
Cevostamab, a FcRH5 bispecific antibody, for RRMM | Joshua Richter, MD | #ASH2024
Video details & playlist

